Edgewise Therapeutics (EWTX) Shares Issued (2020 - 2026)

Edgewise Therapeutics has disclosed Shares Issued across 7 years of filings, most recently posting $12.2 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $12.2 million, up 438.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.7 million (up 107.51% YoY), and the FY2025 annual result was $7.8 million, up 778.72% from the prior year.
• Shares Issued came in at $12.2 million for Q1 2026 at Edgewise Therapeutics, up from -$179.6 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $239.1 million in Q1 2024 to a low of -$235.6 million in Q2 2024.
• The 5-year median for Shares Issued is $105000.0 (2022), against an average of $1.3 million.
• Peak annual rise in Shares Issued reached 1138695.24% in 2024, while the deepest fall reached 74435.65% in 2024.
• Edgewise Therapeutics' Shares Issued stood at -$129.3 million in 2022, then jumped by 100.42% to $541000.0 in 2023, then slipped by 14.05% to $465000.0 in 2024, then sank by 38714.84% to -$179.6 million in 2025, then soared by 106.78% to $12.2 million in 2026.
• The last three Shares Issued figures came in at $12.2 million (Q1 2026), -$179.6 million (Q4 2025), and $186.8 million (Q3 2025), per Business Quant data.